tbuckley/cabot-search huggingface dataset:
Comparison of Response and Survival Outcomes in Standard- and High-Risk Newly Diagnosed Transplant-Eligible Multiple Myeloma (NDMM) Patients Treated with Lenalidomide, Bortezomib and Dexamethasone (RVD) Versus Daratumumab, Lenalidomide, Bortezomib and Dexamethasone (D-RVD)
Authors: Nisha S. Joseph, Jonathan L. Kaufman, Sara Dicamillo, Danielle Roberts, Vikas A. Gupta, Craig C. Hofmeister, Madhav V. Dhodapkar, Lawrence H. Boise, Sagar Lonial, Ajay K. Nooka
Journal: Blood (2023)
Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution
Authors: Arooj Ahmed, Danai Dima, Kerri Row, Fauzia Ullah, Hussein Awada, Diana Basali, Heena Kurish, Mikhaila Rice, Joslyn Rudoni, Marissa Duco, Beth M. Faiman, Jack Khouri, Sandra Mazzoni, Louis S. Williams, Shahzad Raza, Christy J. Samaras, Jason Valent, Faiz Anwer
Journal: Blood (2023)
Primary Endpoint Analysis from a Response Adaptive Phase II Clinical Trial of Carfilzomib, Lenalidomide, Dexamethasone Plus Daratumumab (KRd-Dara) in Patients with Newly Diagnosed Multiple Myeloma (NDMM)
Authors: Manisha Bhutani, Myra Robinson, Shebli Atrash, Barry Paul, Mauricio Pineda-Roman, David Foureau, Cindy Varga, Reed Friend, Xhevahire Begic, Sarah Norek, Tiffany Drennan, Michelle B Anderson, James Symanowski, Peter M. Voorhees, Saad Z Usmani
Journal: Blood (2023)
Long-Term Evaluation of Luspatercept in Erythropoiesis-Stimulating Agent (ESA)-Intolerant/Refractory Patients (pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the Phase 3 MEDALIST Study
Authors: Valeria Santini, Rami S. Komrokji, Guillermo Garcia-Manero, Rena Buckstein, Esther Natalie Oliva, Karen L. Keeperman, Shelonitda Rose, Ana Carolina Giuseppi, Valerie Vilmont, Yinzhi Lai, Dimana Miteva, Barkha Aggarwal, Uwe Platzbecker, Pierre Fenaux, Amer M. Zeidan
Journal: Blood (2023)
Measurable Residual Disease Status By Clonotypic Mass Spectrometry with Easym Assay Predicts Outcomes Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma
Authors: Michael Slade, Abir Khaled, Mark Fiala, Zac McDonald, Mariya Liyasova, Julie Fortier, Mark Zaydman, Sarah Kelley, Zachary David Crees, Mark A. Schroeder, Keith Stockerl-Goldstein, Liqiang Yang, Ravi Vij
Journal: Blood (2023)
MYCT1 Controls Environmental Sensing to Maintain Self-Renewal in Human Hematopoietic Stem Cells
Authors: Julia Aguade-Gorgorio, Yasaman Jami-alahmadi, Vincenzo Calvanese, Maya Kardouh, Iman Fares, Haley Johnson, Valerie Rezek, Mattias Magnusson, Juliana Shin, Karina J Nance, Helen Goodridge, Gay Miriam Crooks, James Wohlschlegel, Feiyang Ma, Yanling Wang, Simone Liebscher, Katja Schenke-Layland, Hanna Mikkola
Journal: Blood (2023)
Combined Single-Cell and Spatial Transcriptomics Unveil the Complex Organization of the Non-Immune Human Bone Marrow Microenvironment during Aging
Authors: Itziar Cenzano, Miguel Cocera, Robert Lehmann, Jin Ye, Amaia Vilas-Zornoza, Patxi San-Martin, Paula Aguirre-Ruiz, Diego Alignani, Aitziber Lopez, Bruno Paiva, Marta Miñana Barrios, Ignacio Sancho Gonzalez, Javier Ruiz, Sarai Sarvide, Purificacion Ripalda-Cemborain, Laura Sudupe, Emma Muiños-Lopez, Vincenzo Lagani, Jesper Tegner, Borja Saez-Ochoa, Isabel A Calvo, David Gomez-Cabrero, Felipe Prosper
Journal: Blood (2023)
The Impact of Treatment-Free Intervals on T-Cell Exhaustion and Clonotypic Diversity in Myeloma Patients Treated with BCMA Bispecific Antibodies
Authors: Florian Eisele, Nazia Afrin, Emilia Stanojkovska, Mara John, Moutaz Helal, Lars Grundheber, Philipp Weis, Christine Riedhammer, Sofie-Katrin Kadel, Max Steinhardt, Johannes Duell, Johannes M Waldschmidt, Hermann Einsele, Angela Riedel, K. Martin Kortüm, Leo Rasche
Journal: Blood (2023)
Real-World Study of Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma: Analysis across a Spectrum of Advanced Disease Stage Medicare Patients in the United States
Authors: Thomas Delea, Aaron Moynahan, Wenzhen Ge, Xue Song, Glenn S. Kroog, Irene Noguera-Troise, Karen Rodriguez Lorenc, Qiufei Ma
Journal: Blood (2023)
Cladribine with Low Dose Cytarabine and Venetoclax Alternated with Azacytidine and Venetoclax for Acute Myeloid Leukemia: Prognostic Analysis of a Phase 2 Clinical Trial
Authors: Alex Bataller, Alexandre Bazinet, Gautam Borthakur, Nicholas J. Short, Elias Jabbour, Koichi Takahashi, Naval Daver, Ghayas C. Issa, Courtney D. DiNardo, Naveen Pemmaraju, Nitin Jain, Guillermo Montalban-Bravo, William G. Wierda, Guillermo Garcia-Manero, Farhad Ravandi, Hagop M. Kantarjian, Tapan M. Kadia
Journal: Blood (2023)
Venetoclax Plus Azacitadine for Middle Aged and Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial
Authors: Rui Huang, Xiaonan Lin, Yuming Zhang, YongZhong Su, Caixia Wang, Jihao Zhou, Zhenqian Huang, Jinxiong Huang, Xiong Zhang, Ying Zhao, Yuexiong Liang, Xiaotao Wang, Xuekui Gu, Honghua He, Yaling Zheng, Sanfang Tu, FeiHeng Chen, Shaoze Lin, Yaya Wang, Ying Dong, Pengcheng Huang, Zenghui Liu, Xiaoli Xu, Zhao Liang, Xuan Zhou, Meifang Li, Man Luo, Ming Wu, Fang Jiang, Qin Liu, Hui Zeng, Chaoyang Song, Yuhua Li
Journal: Blood (2023)
Understanding Resistance Mechanisms and Growth Kinetics of CLL Treated with Covalent and Non-Covalent BTK Inhibitors
Authors: Aishath Naeem, Liang Li, Filippo Utro, Justin Cha, Junko Tsuji, Stacey M Fernandes, Roberta Santos Azevedo, Francesca Morelli, Zunqiu Wang, Samantha J. Shupe, Kahn Rhrissorrakrai, Chaya Levovitz, Brian P Danysh, Alexandria Kluge, Matthew S Davids, Ignaty Leshchiner, Laxmi Parida, Gad Getz, Jennifer R. Brown
Journal: Blood (2023)
Ahemolytic PNH: Clinical Features of a Distinct Phenotype of Paroxysmal Nocturnal Hemoglobinuria
Authors: Zehra Tombul, Waled Bahaj, Merve Ozturk, Bhavisha A. Patel, Alina Dulau-Florea, Ahmet Celal Toprak, Ibrahim F. Ibrahim, Weina Chen, Franklin Fuda, Olisaemeka Ogbue, Carmelo Gurnari, Charles Parker, Neal S. Young, Jaroslaw P. Maciejewski, Munevver Duran, Taha Bat
Journal: Blood (2023)
Maintenance Ruxolitinib Is Associated with Low Rates of Chronic Gvhd Requiring Systemic Treatment in Older Adults with AML/MDS Undergoing Allogeneic HCT: Results of a Phase II Multicenter Trial
Authors: Zachariah Defilipp, Haesook T. Kim, Laura Knight, Suzanne O'Connor, Meghan White, Bhagirathbhai Dholaria, Mark A. Schroeder, Sumithira Vasu, Sameem Abedin, Areej El-Jawahri, Steven McAfee, Yi-Bin Chen, Gabriela S. Hobbs
Journal: Blood (2023)
Identification of Risk Categories from the Advanced-Stage Hodgkin International Prognostic Index (A-HIPI) Model: A Detailed Analysis from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium
Authors: Matthew J. Maurer, Susan K Parsons, Jenica Upshaw, Jonathan W. Friedberg, Andrea Gallamini, Massimo Federico, Eliza A Hawkes, David Hodgson, Peter Johnson, Brian K. Link, Kerry J. Savage, Pier Luigi Zinzani, Andrew M Evens
Journal: Blood (2023)
Access to Chimeric Antigen T-Cell Receptor (CAR-T) Therapies for Patients with Non-Hodgkin Lymphoma (NHL) in the Catchment Area of Oregon
Authors: Somya Khare, Staci Williamson, Brittany O'Barr, Levanto Schachter, Andy Chen, Brandon Hayes-Lattin, Jessica T. Leonard, Amrita Desai, Peter Ferreira-Gandolfo, Denise Lackey, Kevin Christmas, Richard T Maziarz, Eneida R Nemecek
Journal: Blood (2023)
Comparative Study for Haplo, MSD and MUD Allo-Hcts for AML Patients with KMT2A Rearrangement: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Authors: Yishan Ye, Myriam Labopin, Depei Wu, Jia Chen, Tobias Gedde-Dahl, Didier Blaise, Regis Peffault De Latour, Édouard Forcade, Urpu Salmenniemi, Sébastien Maury, Jurjen Versluis, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Jimin Shi, Fabio Ciceri, He Huang, Mohamad Mohty, Norbert Claude Gorin
Journal: Blood (2023)
IL1RAP-Specific T Cell Engager (TCE) Antibody Efficiently Depletes Acute Myeloid Leukemia (AML) Leukemic Stem Cells (LSCs)
Authors: Yi Zhang, Miso Park, Bin Zhang, Lucy Y. Ghoda, Dandan Zhao, Melissa Valerio, Ebtesam Nafie, Xubo Gong, Fang Chen, Yongfang Xu, Katrina Estrella, Kaito Harada, Shawn Sharkas, Hyunjun Kang, Dinh Hoa Hoang, Le Xuan Truong Nguyen, Stephen J. Forman, Idoroenyi Amanam, Flavia Pichiorri, Jie Jin, John C. Williams, Guido Marcucci
Journal: Blood (2023)
Enhancement of Mitochondrial Membrane Potential and Pro-Survival Pathways with Azole Compound C7 Resulting in Expansion of Hematopoietic Stem and Progenitor Cells
Authors: Kelvin YH Liu, Ze Hui Kok, Vikneswari Rajasegaran, Samantha PS Lim, Muhammad Taufiq Jaafar, John Ouyang, Jui Wan Loh, Jing Yi Lee, Abner H Lim, Cedric Chuan Young Ng, Jason Yongsheng Chan, Charles Chuah, Bin Tean Teh, Sudipto Bari, William Ying Khee Hwang
Journal: Blood (2023)
Association of Measurable Residual Disease with Progression-Free Survival in Patients with Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis in the Era of Novel Agents
Authors: Fausto Alfredo Alfredo Rios Olais, Alyssa K. McGary, Elena Juventina Tuna Aguilar, Diana Almader-Douglas, Mazie Tsang, Jose F. Leis, Matthew R. Buras, Talal Hilal
Journal: Blood (2023)
Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826
Authors: Sharon M. Castellino, Hongli Li, Alex F. Herrera, Angela Punnett, Michael Leblanc, Susan K Parsons, David Hodgson, Frank Keller, Richard A. Drachtman, Adam Lamble, Christopher J. Forlenza, Andrew Doan, Sarah C. Rutherford, Andrew M Evens, Richard F. Little, Malcolm A. Smith, Joo Y Song, Sonali M. Smith, Jonathan W. Friedberg, Kara M. Kelly
Journal: Blood (2023)
Persistence of <i>FLT3</i>-TKD in Blood Prior to Allogeneic Transplant Is Associated with Increased Relapse and Death in Adults with AML in First Remission
Authors: Pranay S. Hegde, Georgia Andrew, Gege Gui, Niveditha Ravindra, Devdeep Mukherjee, Zoe Wong, Jeffery J. Auletta, Firas El Chaer, Adam Corner, Steven M. Devine, Antonio M. Jimenez Jimenez, Marcos de Lima, Mark R. Litzow, Partow Kebriaei, Wael Saber, Stephen R. Spellman, Scott L. Zeger, Kristin M. Page, Laura W Dillon, Christopher S. Hourigan
Journal: Blood (2023)
Molecular Subtypes in <i>BCR::ABL1</i>-Positive ALL Are Defined By Cellular Origins and Cooperating Genomic Events
Authors: Lorenz Bastian, Thomas Beder, Malwine Barz, Sonja Bendig, Lorenz Bartsch, Wencke Walter, Nadine Wolgast, Björn Brändl, Christian Rohrandt, Björn-Thore Hansen, Alina M. Hartmann, Katharina Iben, Miriam Bultmann, Johannes Zimmermann, Michael Wittig, Guranda Chitadze, Martin Neumann, Folker Schneller, Walter Fiedler, Björn Steffen, Matthias Stelljes, Christoph Faul, Stefan Schwartz, Franz-Josef Müller, Gunnar Cario, Lana Harder, Claudia Haferlach, Heike Pfeifer, Nicola Goekbuget, Monika Brüggemann, Claudia D Baldus
Journal: Blood (2023)
Investigating the Influence of Germline <i>ATM</i> Variants on Susceptibility to Chronic Lymphocytic Leukemia and Other Malignancies
Authors: Roberta Santos Azevedo, Francesca Morelli, Kiyomi Mashima, Rayan Fardoun, Svitlana Tyekucheva, Stacey M Fernandes, Samantha J. Shupe, Marissa Terra, Anisha Patel, Joseph Yu, Jennifer R. Brown
Journal: Blood (2023)
Phase II, Single Arm, Open Label, Single Center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
Authors: Nicholas Kendsersky, Rebecca Masel, Amman Bhasin, Tingting Zhan, Carol Gung, Mercy George, Frederick Michael Fellin, Allison Zibelli, Avnish Bhatia, Rajan Singla, Michael Ramirez, Andrew E. Chapman, Patrick Mille, Cassandra Thomas, Joanne Filicko-O'Hara, Barbara Pro, Onder Alpdogan, Adam F. Binder, Pierluigi Porcu, Andres Ferber, Sameh Gaballa, Ubaldo Martinez Outschoorn
Journal: Blood (2023)
Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826
Authors: Sarah C. Rutherford, Hongli Li, Alex F. Herrera, Michael Leblanc, Sairah Ahmed, Kelly L. Davison, Carla Casulo, Nancy L. Bartlett, Joseph M Tuscano, Brian Hess, Pallawi Torka, Pankaj Kumar, Ryan W Jacobs, Joo Y Song, Sharon M. Castellino, Brad S. Kahl, John P. Leonard, Sonali M. Smith, Jonathan W. Friedberg, Andrew M Evens
Journal: Blood (2023)
Trial in Progress: A Phase 1 Study of KTX-1001, an Oral, First-in-Class, Selective MMSET Inhibitor in Patients with Relapsed and Refractory Multiple Myeloma
Authors: Jesus G. Berdeja, David Dingli, Sagar Lonial, Andrew J. Yee, Alfred Chung, Cristina Gasparetto, P. Leif Bergsagel, Vivek Roy, Al-Ola Abdallah, Sharmilan Thanendrarajan, Aimaz Afrough, Laura Rosiñol, Suzanne Trudel, Paula Rodriguez Otero, Cyrille Touzeau, Pierre Bories, Soo Bang, Terry Connolly, Michelle Kim, Chad A. Lewis, Bao-Van Tran Linberg, M. Travis Quigley, Ola Landgren, Saad Z Usmani, Maria-Victoria Mateos, David S. Siegel
Journal: Blood (2023)
High-Dose Methotrexate, Ibrutinib and Temozolomide (MIT) for the Treatment of Newly Diagnosed Primary Central Nervous System Lymphoma: A Multi-Center Prospective Phase II Study
Authors: Liqin Ping, Xiaoxiao Wang, Yan Gao, Bing Bai, He Huang, Linbo Cai, Hui Zhou, Changguo Shan, Zhiming Li, Mingyao Lai, Haixia He, Cheng Huang, Haoqing Chen, Ru Feng, Huiqiang Huang
Journal: Blood (2023)
Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies
Authors: Emma Searle, Francesco Forconi, Kim Linton, Alexey Danilov, Pam McKay, David Lewis, Dima El-Sharkawi, Mary Gleeson, John Riches, Sarah G. Injac, Ted Shih, Srinand Nandakumar, May Tan, Ganesh Cherala, Erin Meredith, Graham P. Collins
Journal: Blood (2023)
Prognostic Significance and Clinical Correlations of Myeloid Mutations in Myelofibrosis Based on Their Functional Class
Authors: Valentina Boldrini, Paola Guglielmelli, Giada Rotunno, Chiara Maccari, Giacomo Coltro, Giuseppe Gaetano Loscocco, Francesco Mannelli, Naseema Gangat, Ayalew Tefferi, Alessandro M. Vannucchi
Journal: Blood (2023)
Safety and Pharmacokinetics of Recombinant ADAMTS13 in Patients with Sickle Cell Disease: A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study
Authors: Julie Kanter, Parth Patwari, Payal Desai, Kenneth I. Ataga, Shelley E. Crary, Sophie Lanzkron, Joshua Field, Yu-Che Chung, Linda T. Wang, Björn Mellgård, Van Anh (Vika) Nguyen, Victor R. Gordeuk
Journal: Blood (2023)
Post-Allograft Romidepsin Maintenance Mitigates Relapse Risk and Stimulates the Graft-Versus-Malignancy Effect through Enhanced NK-Cell Cytotoxicity in Patients with T-Cell Malignancies: Final Results of a Phase I/II Trial
Authors: Chitra Hosing, Zachary Braunstein, Eric McLaughlin, Benigno C. Valdez, Borje S. Andersson, Uday R. Popat, Sumithira Vasu, Evandro Bezzera, Gabriela Sanchez-Petitto, Sarah A Wall, Samantha M. Jaglowski, Sam Penza, Hannah Choe, Lai Wei, Robin Nakkula, Alex Cash, Richard E. Champlin, Marcos de Lima, Steven M. Devine, Dean Anthony Lee, Jonathan E. Brammer
Journal: Blood (2023)
Broad Superiority of Zanubrutinib (Zanu) Over Bendamustine + Rituximab (BR) Across Multiple High-Risk Factors: Biomarker Subgroup Analysis in the Phase 3 SEQUOIA Study in Patients With Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) without del(17p)
Authors: Vanitha Ramakrishnan, Linlin Xu, Jason C. Paik, Carol Marimpietri, Eric Shen, Xiaoxi Dong, Jessica Li, Andreas Agathangelidis, Tian Tian, Aileen Cleary Cohen, Tadeusz Robak, Constantine S. Tam, Paolo Ghia, Andrew Rawstron, Jennifer R. Brown
Journal: Blood (2023)
Fatty Acid Binding Protein FABP5 Inhibition Activates Retinoic Acid Signaling and Induces Differentiation in Acute Myeloid Leukemia
Authors: Divya Jyoti Singh, Metis Hasipek, Dongxu Jiang, Daniel Vail, Yahan Zhang, Jill Durkin, Naomi Kawashima, Simon Schlanger, Xiaorong Gu, Jaroslaw P. Maciejewski, Yogenthiran Saunthararajah, Hetty E. Carraway, Babal Kant Jha
Journal: Blood (2023)
Important Role for Glutamine in Human and Mouse TME Models of CLL ; Towards Development of a PET Tracer As a Novel Diagnostic Tool
Authors: Helga Simon-Molas, Chiara Montironi, Gaspard Cretenet, Sjoerd P.P. van Eeden, Rosita Del Prete, Zhenghao Chen, Ingrid A.M. Derks, Mariska Verlaan, Arnon P. Kater, Wissam Beaino, Anna Kabanova, Josée M. Zijlstra, Albert D. Windhorst, Eric Eldering
Journal: Blood (2023)
Favorable Outcomes for High-Risk MDS and Oligoblastic AML with MDS-Related Changes with Reduced Intensity Allogeneic Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide
Authors: Ilias Sinanidis, Michael Jamie Hochman, Hua-Ling Tsai, Michael P Randall, Brandon Bonilla, Ravi Varadhan, Alexander Joseph Ambinder, Amy E. DeZern, Theodoros Karantanos
Journal: Blood (2023)
Efficacy and Safety Outcomes in Patients with Cancer-Associated Thromboembolism Treated with Tinzaparin According to the Tumor Site: Meta-Analysis of Prospective Studies Involving 1413 Individual Patients' Data
Authors: Isabelle Mahe, Céline Chapelle, Luis Jara-Palomares, Olivier Sanchez, Philippe Girard, Guy Meyer, Agnes Yuet Ying Lee, Géraldine Poénou, Silvy Laporte
Journal: Blood (2023)
Retrospective Analysis of Clofarabine Salvage Therapy in Refractory Multifocal Langerhans Cell Histiocytosis (LCH)
Authors: Deevyashali Parekh, Howard Lin, Kenneth L. McClain, Nitya Gulati, Olive S. Eckstein, Nader Kim El-Mallawany, Jennifer Elise Agrusa, Carl E Allen
Journal: Blood (2023)
Somatic TET2 Mutations Prime the Immune System for Response to Immune Checkpoint Blockade
Authors: Robert Vanner, Andy G.X. Zeng, Michelle Chan-Seng-Yue, Suraj Bansal, Elisa Donato, Liqing Jin, Sofia Genta, Enrique Sanz Garcia, Steven M. Chan, Andreas Trumpp, John E. Dick
Journal: Blood (2023)
Alpha-Pinene As a Novel Therapeutic Agent for T-Cell Tumors
Authors: Masaya Abe, Noboru Asada, Maiko Kimura, Chie Fukui, Daisuke Yamada, Ziyi Wang, Masayuki Miyake, Takeshi Takarada, Mitsuaki Ono, Michinori Aoe, Wataru Kitamura, Masayuki Matsuda, Takashi Moriyama, Akifumi Matsumura, Yoshinobu Maeda
Journal: Blood (2023)
Clinical Outcomes of Patients with Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 Elara 3-Year Follow-up
Authors: Stephen J Schuster, Nathan Fowler, Michael Dickinson, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie L. Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, Phoebe Joy Ho, Jose A. Perez-Simon, Andy Chen, Loretta J. Nastoupil, Bastian von Tresckow, Andrés José María Ferreri, Takanori Teshima, Piers Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Zinzani, Ram Malladi, Aiesha Zia, Rakesh Awasthi, Ines Paule, Davide Germano, Roberto Javier Ramos, Pei Hsu, Catherine Thieblemont, Martin Dreyling
Journal: Blood (2023)
Trial in Progress: An Open-Label Expansion Trial Evaluating the Safety, PK/PD, and Clinical Activity of Emavusertib (CA-4948) + Ibrutinib in R/R Primary CNS Lymphoma
Authors: Christian Grommes, Grzegorz S. Nowakowski, Allison C. Rosenthal, Matthew A Lunning, Radhakrishnan Ramchandren, Lucia Regales, Meaghan Fowle, Maureen Lane, Catherine Wang, Antonio Omuro, Lori A. Leslie, Carole Soussain, Anna Paulina Dabrowska-Iwanicka, Andrés José María Ferreri, Han Tun
Journal: Blood (2023)
Recombinant Human Diamine Oxidase Against Histamine Induced Shock - Implications for Mast Cell Activation Syndrome
Authors: Matthias Weiss-Tessbach, Birgit Reiter, Felix Kosta, Martin Murauer, Elisabeth Gludovacz, Thomas Böhm, Bernd Jilma, Marlene Rager-Resch
Journal: Blood (2023)
Luspatercept for the Treatment of Anemia in Non-Transfusion-Dependent β-Thalassemia: Final Safety and Efficacy Data from the BEYOND Trial
Authors: Ali T Taher, Vip Viprakasit, Antonis Kattamis, Silverio Perrotta, Paolo Ricchi, John B. Porter, Thomas D Coates, Gian Luca Forni, Khaled M. Musallam, Oriana Esposito, Ana Carolina Giuseppi, Wen-Ling Kuo, Marta Reverte, Richard Wei, Luciana Moro Bueno, Maria Domenica Cappellini
Journal: Blood (2023)
Outcomes of Patients with Relapsed/Refractory Lymphoplasmacytic Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis
Authors: Yazeed Sawalha, Shayna R Sarosiek, Rina Li Welkie, Sherif Seif, Shrinjaya Thapa, Saurabh Zanwar, Kirk Cahill, Rachel Treitman, Haikoo Shah, Shagun Arora, Georgios Pongas, Allison Winter, Ajay Major, Peter A. Riedell, Maria Lia Palomba, Prashant Kapoor, Ariel F. Grajales-Cruz, Kenneth H. Shain, Sheeba K. Thomas, Jorge J. Castillo
Journal: Blood (2023)
Blood Coagulation and Platelet Function Are Impaired By the ARP2 p.R258G Variant in Mice
Authors: Caitlin Schneider, Marisa A Brake, Amy Siebert-Mckenzie, Adrianna Jurek, Audrey C Cleuren, Linzi Hobbs, Alexander Johnston, Michael Powers, Azaj Ahmed, Melissa Jensen, Javier Menendez, Sanjana Dayal, Anthony Washington, Randal Joseph Westrick
Journal: Blood (2023)
Long-Term Follow-up of AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation after Primary Induction Failure
Authors: Miriam Mozaffari Jovein, Gabriele Ihorst, Jesus Duque Afonso, Ralph Wäsch, Claudia Wehr, Hartmut Bertz, Justus Duyster, Robert Zeiser, Jürgen Finke, Florian Scherer
Journal: Blood (2023)
Real-World Outcomes of Brexucabtagene Autoleucel (brexu-cel) for Relapsed or Refractory (R/R) Adult B-Cell Acute Lymphoblastic Leukemia (B-cell ALL): Evidence from the CIBMTR Registry
Authors: Evandro Bezerra, Taha Itani, Kistada Wudhikarn, Miguel-Angel Perales, Yang Yang, Usama Gergis, Ahmed Aribi, LaQuisa C. Hill, Nitin Jain, Jessica T. Leonard, Forat Lutfi, Soyoung Kim, Matthew Bye, Hai-Lin Wang, Tsveta Hadjivassileva, Liana Nikolaenko, Ioana Kloos, Amina Abdeldaim, David Dalton, Hairong Xu, Marcelo Pasquini, Partow Kebriaei
Journal: Blood (2023)
Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone (DIPD) As Salvage Therapy in Early Relapsed/Refractory Multiple Myeloma
Authors: Anupama Kumar, Aaron S. Rosenberg, Edward D. Ball, Sarah M. Larson, Lindsey Sirianni, Carolyn M. Mulroney, Caitlin L. Costello
Journal: Blood (2023)
Clinical Experience with Cranial Nerve Impairment in the CARTITUDE-1, CARTITUDE-2 Cohorts A, B, and C, and Cartitude-4 Studies of Ciltacabtagene Autoleucel (Cilta-cel)
Authors: Niels W.C.J. Van De Donk, Surbhi Sidana, Jordan M. Schecter, Carolyn Chang Jackson, Nikoletta Lendvai, Kevin C De Braganca, Ana Slaughter, Carolina Lonardi, Philip Vlummens, Helen Varsos, Christina Corsale, Deepu Madduri, Shirin Jadidi, Junchen Gu, Hao Zhao, Katherine Li, Erin Lee, Loreta Marquez, Man Zhao, Tzu-min Yeh, Diana Chen, Erika Florendo, Nitin Patel, Muhammad Akram, Jaime Gellego Perez-Larraya, Paula Rodriguez Otero
Journal: Blood (2023)
Patient Values, Information Preferences, and Decisional Preferences Among Older Adults with Acute Myeloid Leukemia
Authors: Kah Poh (Melissa) Loh, Soroush Mortaz-Hedjri, Ying Wang, Marissa Locastro, Sally Norton, Jason H. Mendler, Jane L. Liesveld, Eric J Huselton, Marielle Jensen-Battaglia, Kathryn Buettner, Jenae Davis, Heidi Klepin, Daniel R. Richardson
Journal: Blood (2023)
AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
Authors: Tara O. Henderson, Boyu Hu, Frank Keller, Qinglin Pei, Yue Wu, Bradford Hoppe, Sarah Milgrom, Song Yao, Niloufer Khan, Lisa Giulino Roth, Raymond Mailhot, Steve Cho, Susan K Parsons, Justine M. Kahn, Adam S Duvall, Pamela S. Hinds, Ann LaCasce, Natalie S. Grover, Pamela B. Allen, Andrew M Evens, Heiko Schoder, Sharon M. Castellino, Kara M. Kelly
Journal: Blood (2023)
Chronic Lymphocytic Leukemia (CLL) in Adolescents and Young Adults (AYA): Clinical Characteristics, Prognostic Factors and Survival for 498 Patients
Authors: Henry Becerra, Nosakhare Paul Ilerhunmwuwa, Mustafa Wasifuddin, Ifeanyi Nnamdi Uche, Jen-Chin Wang
Journal: Blood (2023)